Access Bio (950130 KS): COVID-19 Rapid Tests Demand Lose Sheen Sending Share Prices Down to Lows
Overdependence on COVID-19 test products sours the revenue outlook for Access Bio. With the declining number of new infections globally, the demand...
343 Views
KOSDAQ150 Index Rebalance Preview (Dec 2022): Changes Galore Early in the Review Period
One third of the way through the review period, we see 11 potential changes. The potential adds have outperformed the potential deletes and there...
641 Views
KOSDAQ150 Index Rebalance Preview: 15 Potential Changes and Large Turnover
At the end of the review period, we see 15 potential changes for the KOSDAQ150 index. Most of the changes are high probability. The adds could...
888 Views
KOSDAQ150 Index Rebalance Preview: Here Comes the Pullback
With 85% of the review period complete, we see 16 changes for the KQ150 Index at the Dec rebal. The potential adds have outperformed the deletes...
667 Views
KOSDAQ150 Index Rebalance Preview: Inclusions Outperforming as Short Sell Ban Helps
Halfway through the review period, we see 15 potential changes to the index. The potential inclusions are outperforming the exclusions as short...
513 Views